Importer of Controlled Substances Application: Aveva Drug Delivery Systems, Inc., 8303-8304 [2025-01766]
Download as PDF
8303
Federal Register / Vol. 90, No. 17 / Tuesday, January 28, 2025 / Notices
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and UHD Alliance
intends to file additional written
notifications disclosing all changes in
membership.
On June 17, 2015, UHD Alliance filed
its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on July 17, 2015 (80 FR
42537).
The last notification was filed with
the Department on October 8, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on December 20, 2024 (89 FR
104209).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Project Navigator, Ltd. (A
Verdantas Company), Tustin, CA, has
become a party to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and PERF intends
to file additional written notifications
disclosing all changes in membership.
On February 10, 1986, PERF filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on March 14, 1986 (51 FR 8903).
The last notification was filed with
the Department on July 15, 2024. A
notice was published in the Federal
Register pursuant to section 6(h) of the
Act on October 11, 2024 (89 FR 82632).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2025–01818 Filed 1–27–25; 8:45 am]
BILLING CODE P
[FR Doc. 2025–01824 Filed 1–27–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
DEPARTMENT OF JUSTICE
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Petroleum Environmental
Research Forum
Drug Enforcement Administration
Notice is hereby given that, on
December 17, 2024, pursuant to section
6(a) of the National Cooperative
Research and Production Act of 1933,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Petroleum Environmental Research
Forum (‘‘PERF’’) filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
[Docket No. DEA–1449]
Importer of Controlled Substances
Application: Vici Health Sciences, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Vici Health Sciences, LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
SUMMARY:
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before February 27, 2025. Such
persons may also file a written request
for a hearing on the application on or
before February 27, 2025.
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on October 4, 2024, Vici
Health Sciences, LLC, 6655 Amberton
Drive, Suite O, Elkridge, Maryland
21075–6202 applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
ddrumheller on DSK120RN23PROD with NOTICES1
Fentanyl-related compounds as defined in 21 CFR 1308.11(h) ..................................................................................................
The company plans to import the
listed controlled substance as part of a
manufacturing process supporting
research and clinical trial efforts. No
other activity for this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
VerDate Sep<11>2014
17:49 Jan 27, 2025
Jkt 265001
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
PO 00000
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances
Application: Aveva Drug Delivery
Systems, Inc.
Drug Enforcement
Administration, Justice.
AGENCY:
Frm 00047
Fmt 4703
Sfmt 4703
I
[Docket No. DEA–1454]
[FR Doc. 2025–01767 Filed 1–27–25; 8:45 am]
BILLING CODE 4410–09–P
9850
Schedule
E:\FR\FM\28JAN1.SGM
28JAN1
8304
ACTION:
Federal Register / Vol. 90, No. 17 / Tuesday, January 28, 2025 / Notices
Notice of application.
Aveva Drug Delivery Systems,
Inc. has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before February 27, 2025. Such
persons may also file a written request
for a hearing on the application on or
before February 27, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on October 9, 2024, Aveva
Drug Delivery Systems, Inc., 3250
Commerce Parkway, Miramar, Florida
33025–3907, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
Drug
code
Controlled substance
Thebaine ........................
I
9333
Schedule
III
The company plans to import the
listed controlled substance for analytical
purposes only. No other activity for this
drug code is authorized for this
registration.
VerDate Sep<11>2014
17:49 Jan 27, 2025
Jkt 265001
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–01766 Filed 1–27–25; 8:45 am]
BILLING CODE 4410–09–P
NATIONAL ARCHIVES AND RECORDS
ADMINISTRATION
[NARA–25–0002; NARA–2025–014]
Records Schedules; Availability and
Request for Comments
National Archives and Records
Administration (NARA).
ACTION: Notice of availability of
proposed records schedules; request for
comments.
AGENCY:
The National Archives and
Records Administration (NARA)
publishes notice of certain Federal
agency requests for records disposition
authority (records schedules). We
publish notice in the Federal Register
and on regulations.gov for records
schedules in which agencies propose to
dispose of records they no longer need
to conduct agency business. We invite
public comments on such records
schedules.
SUMMARY:
We must receive responses on
the schedules listed in this notice by
March 17, 2025.
ADDRESSES: To view a records schedule
in this notice, or submit a comment on
one, use the following address: https://
www.regulations.gov/docket/NARA-250002/document.
This is a direct link to the schedules
posted in the docket for this notice on
regulations.gov. You may submit
comments by the following method:
Federal eRulemaking Portal: https://
www.regulations.gov. On the website,
enter either of the numbers cited at the
top of this notice into the search field.
This will bring you to the docket for this
notice, in which we have posted the
records schedules open for comment.
Each schedule has a ‘comment’ button
so you can comment on that specific
schedule. For more information on
regulations.gov and on submitting
comments, see their FAQs at https://
www.regulations.gov/faq.
If you are unable to comment via
regulations.gov, you may email us at
DATES:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
request.schedule@nara.gov for
instructions on submitting your
comment. You must cite the control
number of the schedule you wish to
comment on. You can find the control
number for each schedule in
parentheses at the end of each
schedule’s entry in the list at the end of
this notice.
FOR FURTHER INFORMATION CONTACT:
Kimberly Richardson, Strategy and
Performance Division, by email at
regulation_comments@nara.gov or at
301–837–2902. For information about
records schedules, contact Records
Management Operations by email at
request.schedule@nara.gov or by phone
at 301–837–1799.
SUPPLEMENTARY INFORMATION:
Public Comment Procedures
We are publishing notice of records
schedules in which agencies propose to
dispose of records they no longer need
to conduct agency business. We invite
public comments on these records
schedules, as required by 44 U.S.C.
3303a(a), and list the schedules at the
end of this notice by agency and
subdivision requesting disposition
authority.
In addition, this notice lists the
organizational unit(s) accumulating the
records or states that the schedule has
agency-wide applicability. It also
provides the control number assigned to
each schedule, which you will need if
you submit comments on that schedule.
We have uploaded the records
schedules and accompanying appraisal
memoranda to the regulations.gov
docket for this notice as ‘‘other’’
documents. Each records schedule
contains a full description of the records
at the file unit level as well as their
proposed disposition. The appraisal
memorandum for the schedule includes
information about the records.
We will post comments, including
any personal information and
attachments, to the public docket
unchanged. Because comments are
public, you are responsible for ensuring
that you do not include any confidential
or other information that you or a third
party may not wish to be publicly
posted. If you want to submit a
comment with confidential information
or cannot otherwise use the
regulations.gov portal, you may contact
request.schedule@nara.gov for
instructions on submitting your
comment.
We will consider all comments
submitted by the posted deadline and
consult as needed with the Federal
agency seeking the disposition
authority. After considering comments,
E:\FR\FM\28JAN1.SGM
28JAN1
Agencies
[Federal Register Volume 90, Number 17 (Tuesday, January 28, 2025)]
[Notices]
[Pages 8303-8304]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-01766]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1454]
Importer of Controlled Substances Application: Aveva Drug
Delivery Systems, Inc.
AGENCY: Drug Enforcement Administration, Justice.
[[Page 8304]]
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Aveva Drug Delivery Systems, Inc. has applied to be registered
as an importer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
February 27, 2025. Such persons may also file a written request for a
hearing on the application on or before February 27, 2025.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on October 9, 2024, Aveva Drug Delivery Systems, Inc.,
3250 Commerce Parkway, Miramar, Florida 33025-3907, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Thebaine............................... 9333 II
------------------------------------------------------------------------
The company plans to import the listed controlled substance for
analytical purposes only. No other activity for this drug code is
authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-01766 Filed 1-27-25; 8:45 am]
BILLING CODE 4410-09-P